As Allstate Corp (ALL) Stock Rose, Boston Partners Has Raised Stake by $96.62 Million

The Allstate Corporation (NYSE:ALL) LogoInvestors sentiment increased to 0.89 in 2018 Q2. Its up 0.08, from 0.81 in 2018Q1. It improved, as 46 investors sold ALL shares while 286 reduced holdings. 60 funds opened positions while 237 raised stakes. 254.16 million shares or 2.24% less from 260.00 million shares in 2018Q1 were reported. Suntrust Banks Inc has invested 0.19% in The Allstate Corporation (NYSE:ALL). Farmers Merchants, Nebraska-based fund reported 551 shares. Farmers holds 3,998 shares or 0.11% of its portfolio. Tcw Grp Incorporated accumulated 10,638 shares. Fiduciary holds 0.08% or 29,088 shares in its portfolio. Saybrook Capital Nc reported 2,533 shares. Pennsylvania-based Janney Cap Management Ltd has invested 0.02% in The Allstate Corporation (NYSE:ALL). Stevens First Principles Investment Advsr holds 1.94% of its portfolio in The Allstate Corporation (NYSE:ALL) for 35,221 shares. Bb&T Secs Ltd reported 138,715 shares. Putnam Lc holds 95,286 shares. 1.43M are held by Sumitomo Mitsui Trust Hldg. Nomura Asset Mngmt Com Ltd, Japan-based fund reported 58,061 shares. Panagora Asset Management has 1.90M shares for 0.69% of their portfolio. Comerica Securities Incorporated reported 0.05% of its portfolio in The Allstate Corporation (NYSE:ALL). Cetera Advisor Lc holds 6,040 shares.

Since September 13, 2018, it had 0 insider purchases, and 2 selling transactions for $1.10 million activity. Another trade for 696 shares valued at $64,118 was made by Merten Jesse E on Wednesday, November 7.

Boston Partners increased its stake in Allstate Corp (ALL) by 11.24% based on its latest 2018Q2 regulatory filing with the SEC. Boston Partners bought 1.06M shares as the company’s stock rose 4.62% with the market. The institutional investor held 10.51 million shares of the property-casualty insurers company at the end of 2018Q2, valued at $959.41M, up from 9.45M at the end of the previous reported quarter. Boston Partners who had been investing in Allstate Corp for a number of months, seems to be bullish on the $30.60B market cap company. The stock decreased 2.77% or $2.53 during the last trading session, reaching $88.85. About 1.54 million shares traded. The Allstate Corporation (NYSE:ALL) has risen 6.22% since November 14, 2017 and is uptrending. It has underperformed by 9.40% the S&P500.

Boston Partners, which manages about $53.18 billion and $83.44B US Long portfolio, decreased its stake in Pfizer Inc (NYSE:PFE) by 107,782 shares to 29.09 million shares, valued at $1.06B in 2018Q2, according to the filing. It also reduced its holding in Energen Corp (NYSE:EGN) by 52,537 shares in the quarter, leaving it with 6.11 million shares, and cut its stake in Alliance Data Systems Corp (NYSE:ADS).

More news for The Allstate Corporation (NYSE:ALL) were recently published by: Benzinga.com, which released: “Q3 Earnings Preview For Allstate” on October 31, 2018. Seekingalpha.com‘s article titled: “Allstate -3.4% after Q3 misses consensus by 13%” and published on October 31, 2018 is yet another important article.

The Allstate Corporation (NYSE:ALL) Ratings Coverage

Among 4 analysts covering Allstate (NYSE:ALL), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Allstate had 8 analyst reports since July 16, 2018 according to SRatingsIntel. The firm has “Neutral” rating given on Tuesday, August 7 by FBR Capital. The firm has “Neutral” rating given on Wednesday, July 18 by Buckingham Research. The stock of The Allstate Corporation (NYSE:ALL) earned “Buy” rating by Citigroup on Friday, October 12. As per Tuesday, August 28, the company rating was maintained by Credit Suisse. Citigroup maintained The Allstate Corporation (NYSE:ALL) on Friday, July 20 with “Buy” rating. The rating was maintained by Citigroup on Friday, November 2 with “Buy”. FBR Capital maintained it with “Neutral” rating and $88 target in Monday, July 16 report.

The Allstate Corporation (NYSE:ALL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.